BioSpace News Archive

Prokarium, a biopharmaceutical company pioneering the oncology field of microbial immunotherapy, announced the appointment of Livija Deban, PhD, as Chief Scientific Officer.

Fact.MR – A Market Research and Competitive Intelligence Provider: As per the newly released data by Fact.MR, the global sterile compounding pharmacies market reached US$ 5.07 Bn in 2020 and is projected to surpass US$ 8.9 Bn by the end of 2031.

Spheroids and organoids are 3D models or cultures that can recapitulate organ features ex vivo, thereby opening new paths to diagnostic and therapeutic assessment.

Winner Medical is set to showcase its full set of advanced solutions for wound care and O.R. infection prevention at MEDICA 2021 which is slated to run from November 15-18 in Düsseldorf, Germany

Mogrify Limited, a biopharmaceutical company pioneering the development of a new class of in vivo reprogramming therapies and transforming the development of ex vivo cell therapies, announced the appointment of Tom Graney CFA as Non-Executive Director, Audit Chair and Capital Markets Advisor.

OraSure Technologies, Inc., a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced that the EUA for its InteliSwab™ COVID-19 rapid tests has been amended by the U.S. Food and Drug Administration to only require one test for individuals with symptoms of COVID-19.

Voyager Therapeutics, Inc. today reported third quarter 2021 financial and operating results.

SAGA Diagnostics AB has entered into an assay development agreement with the global, science-led biopharmaceutical company AstraZeneca (LSE/STO/Nasdaq: AZN).

Lyra Therapeutics, Inc. will report third quarter 2021 financial results on Tuesday, November 9, 2021 after the close of market.

Sutro Biopharma, Inc. today announced that Chief Executive Officer, Bill Newell , will participate in three upcoming virtual investor conferences.